Related Experiment Video
Updated: Jul 10, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Percutaneous transluminal angioplasty and stenting for carotid artery stenosis
Insights
Endovascular treatment for carotid artery stenosis shows mixed results compared to surgery. While it may reduce cranial neuropathy, carotid endarterectomy remains the recommended treatment of choice due to heterogeneous trial data.
Area of Science:
- Vascular Surgery
- Interventional Neurology
- Clinical Trials Methodology
Background:
- Endovascular treatment, including balloon angioplasty and stent insertion, presents a potential alternative to traditional carotid endarterectomy for managing carotid artery stenosis.
- The clinical utility of endovascular approaches necessitates a thorough comparison against established surgical and medical interventions.
Purpose of the Study:
- To systematically evaluate the comparative benefits and risks associated with endovascular treatment versus carotid endarterectomy and medical therapy for carotid artery stenosis.
- To determine if endovascular interventions offer a superior or equivalent safety and efficacy profile in managing carotid artery disease.
Main Methods:
- A comprehensive literature search was conducted across multiple databases (Cochrane Stroke Group, CENTRAL, MEDLINE, EMBASE, Science Citation Index) up to March 2007.
- Randomized controlled trials comparing endovascular treatment with carotid endarterectomy or medical therapy for carotid artery stenosis were selected.
- Data extraction and quality assessment were performed independently by two review authors to ensure reliability.
Main Results:
- Analysis of 12 trials (3227 patients) indicated that carotid endarterectomy (surgery) was favored for the primary outcome of any stroke or death within 30 days (OR 1.39, P=0.02).
- Endovascular treatment showed benefits in reducing cranial neuropathy (OR 0.07, P<0.01) but had non-significant results for 30-day neurological complications or death (OR 0.62) due to heterogeneity.
- No significant differences were observed between endovascular treatment and surgery for 30-day stroke, myocardial infarction, or death (OR 1.11), long-term stroke (OR 1.00), or in asymptomatic patients (OR 1.06).
Conclusions:
- The heterogeneity across trials, including patient populations, endovascular procedures, and follow-up durations, complicates definitive interpretation.
- Early cessation of five trials may have overestimated endovascular treatment risks.
- Current evidence does not support a shift away from recommending carotid endarterectomy as the primary treatment for suitable cases of carotid artery stenosis.
Background:
Endovascular treatment by transluminal balloon angioplasty or stent insertion may be a useful alternative to carotid endarterectomy.
Objectives:
To assess the benefits and risks of endovascular treatment compared with carotid endarterectomy or medical therapy.
Search Strategy:
We searched the Cochrane Stroke Group trials register (last searched 14 March 2007) and the following bibliographic databases: Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library, Issue 1, 2007), MEDLINE (1950 to March 2007), EMBASE (1980 to March 2007) and Science Citation Index (1945 to March 2007). We also contacted researchers in the field.
Selection Criteria:
We selected randomised trials of endovascular treatment compared with endarterectomy or medical therapy for carotid artery stenosis.
Data Collection And Analysis:
One review author independently applied the inclusion criteria, extracted data and assessed trial quality. Search results were validated by a second review author.
Main Results:
Data were available from 12 trials (3227 patients) but not all contributed to each analysis. The primary outcome comparison of any stroke or death within 30 days of treatment favoured surgery (odds ratio (OR) 1.39, P = 0.02, not significant (NS) in the random-effects model). The following outcome comparisons favoured endovascular treatment over surgery: cranial neuropathy (OR 0.07, P < 0.01); 30 day neurological complication or death (OR 0.62, P = 0.004, NS in the random-effects model, with significant heterogeneity). The following outcome comparisons showed little difference between endovascular treatment and surgery: 30 day stroke, myocardial infarction or death (OR 1.11, P = 0.57 with significant heterogeneity); stroke during long-term follow up (OR 1.00). Comparison between endovascular treatment with or without protection device showed no significant difference in 30 day stroke or death (OR 0.77, P = 0.42 with significant heterogeneity). Analysis of stroke or death within 30 days of the procedure in asymptomatic carotid stenosis showed no difference (OR 1.06, P = 0.96). In patients not suitable for surgery, there was no significant difference in 30 day stroke or death (OR 0.39, P = 0.09 with significant heterogeneity).
Authors' Conclusions:
The data are difficult to interpret because the trials are heterogeneous (different patients, endovascular procedures, and duration of follow up) and five trials were stopped early, perhaps leading to an over-estimate of the risks of endovascular treatment. The pattern of effects on different outcomes does not support a change in clinical practice away from recommending carotid endarterectomy as the treatment of choice for suitable carotid artery stenosis.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis III: Management
Angina IV: Management
Cardiac Catheterization I: Pre-Procedure Overview
Acute Coronary Syndrome I: Introduction